By Colin Kellaher
Revvity's board has authorized a new $1 billion share-repurchase program.
Revvity on Monday said the new buyback replaces the $1 billion repurchase program the Waltham, Mass., health-sciences company announced last October, which had $414.5 million remaining as of June 29.
Revvity, which had nearly 116.1 million shares outstanding as of Aug. 1, sports a market capitalization of roughly $11.5 billion.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 27, 2025 06:38 ET (10:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.